EUVIMEDEUVIMED entdecken
Open Access

Tricarbonyl Rhenium‐Based PROTACs Degrade the SARS‐CoV‐2 Mpro Protease

Liuruiqi Luo, Yuxiang Lu, He Meng, Wenkai Lin, Kai Lu, Jing Wang, Jinghui Wang, Yufang Xiong, Zong-Wan Mao, Wei Xia iD

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202503042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Liuruiqi Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, IGCME, School of Chemistry, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Rhenium, SARS-CoV-2, Coronavirus 3C Proteases, Coordination Complexes. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation (TPD) using proteolysis‐targeting chimeras (PROTACs) offers advantages over occupancy‐based inhibitors but faces challenges, including ligand discovery and cellular permeability. To address these limitations, we developed Re2 , a metallo‐PROTAC integrating a covalent rhenium(I) complex warhead targeting SARS‐CoV‐2 main protease (Mpro) Cys145 with the cereblon E3 ligase ligand pomalidomide. Re2 induced effective intracellular Mpro degradation at 100 nM within 72 h, which is significantly below its parent complex's enzymatic inhibition concentration. In vitro and ex vivo studies confirmed covalent Mpro binding and ubiquitin‐proteasome system‐dependent degradation. Crucially, Re2 exhibited three‐ to fourfold higher cellular uptake and greater intracellular accumulation than its demetallated organic counterpart, demonstrating that metalation overcomes intrinsic PROTAC permeability barriers. This work establishes metallo‐PROTACs, exploiting the tunable coordination chemistry of metal complexes for enhanced target engagement and cellular delivery, as a potent strategy for designing high‐potent PROTACs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RheniumSARS-CoV-2Coronavirus 3C ProteasesCoordination ComplexesProteolysis Targeting ChimeraHumansProteolysisThalidomideUbiquitin-Protein LigasesProteasome Endopeptidase ComplexAntiviral Agents

Stichwörter der Autor:innen

PROTACSARS‐CoV‐2 main proteasemetal complexesprotein degradation

Substanzen

Proteolysis Targeting ChimeraRheniumCoronavirus 3C ProteasespomalidomideThalidomideCoordination ComplexesUbiquitin-Protein LigasesProteasome Endopeptidase Complex3C-like proteinase, SARS-CoV-2Antiviral Agents

Autor:innen und Institutionen

  • MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, IGCME, School of Chemistry, Sun Yat-Sen University, Guangzhou, China.

ORCID-Profile: Wei Xia

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Luo, L., Lu, Y., Meng, H., Lin, W., Lu, K., Wang, J., Wang, J., Xiong, Y., Mao, Z. W., & Xia, W. (2025). Tricarbonyl Rhenium‐Based PROTACs Degrade the SARS‐CoV‐2 Mpro Protease. Chemistry – A European Journal. https://doi.org/10.1002/chem.202503042

Vancouver

Luo L, Lu Y, Meng H, Lin W, Lu K, Wang J, et al. Tricarbonyl Rhenium‐Based PROTACs Degrade the SARS‐CoV‐2 Mpro Protease. Chemistry – A European Journal. 2025. doi:10.1002/chem.202503042

BibTeX
@article{Luo2025,
  author = {Luo, Liuruiqi and Lu, Yuxiang and Meng, He and Lin, Wenkai and Lu, Kai and Wang, Jing and Wang, Jinghui and Xiong, Yufang and Mao, Zong-Wan and Xia, Wei},
  title = {Tricarbonyl Rhenium‐Based PROTACs Degrade the SARS‐CoV‐2 Mpro Protease},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202503042}
}
Kostenlos starten →